Michael Brundage

17.8k total citations · 2 hit papers
276 papers, 10.4k citations indexed

About

Michael Brundage is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Brundage has authored 276 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Oncology, 74 papers in Economics and Econometrics and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Brundage's work include Health Systems, Economic Evaluations, Quality of Life (58 papers), Cancer survivorship and care (51 papers) and Patient-Provider Communication in Healthcare (50 papers). Michael Brundage is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (58 papers), Cancer survivorship and care (51 papers) and Patient-Provider Communication in Healthcare (50 papers). Michael Brundage collaborates with scholars based in Canada, United States and United Kingdom. Michael Brundage's co-authors include Deb Feldman‐Stewart, William J. Mackillop, Judith Davidson, Melanie Calvert, Diane Davies, Jane Blazeby, Alistair MacLean, David Moher, Dennis A. Revicki and Karleen Schulze and has published in prestigious journals such as The Lancet, JAMA and Nature Medicine.

In The Last Decade

Michael Brundage

264 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reporting of Patient-Reported Outcomes in Randomized Trials

2013 890 citations Melanie Calvert, Michael Brundage et al. profile →
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

2011 382 citations Padraig Warde, Keyue Ding et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Brundage Canada	54	3.6k	3.1k	1.9k	1.8k	1.7k	276	10.4k
Nandita Mitra United States	55	2.0k 0.6×	2.2k 0.7×	1.7k 0.9×	2.0k 1.1×	1.4k 0.8×	302	11.2k
Shabbir M.H. Alibhai Canada	55	3.9k 1.1×	4.2k 1.4×	1.1k 0.6×	1.8k 1.0×	1.4k 0.8×	437	11.4k
Arnold L. Potosky United States	70	7.3k 2.0×	6.9k 2.3×	1.7k 0.9×	2.8k 1.6×	2.5k 1.5×	175	17.2k
Jim C. Hu United States	57	2.7k 0.8×	7.2k 2.4×	776 0.4×	2.9k 1.6×	986 0.6×	357	11.7k
Rodney L. Dunn United States	58	3.2k 0.9×	6.5k 2.1×	1.1k 0.6×	4.4k 2.5×	788 0.5×	279	14.0k
Wendy R. Parulekar Canada	30	5.2k 1.4×	3.1k 1.0×	1.1k 0.6×	2.3k 1.3×	1.3k 0.8×	131	14.9k
Ann S. Hamilton United States	63	5.0k 1.4×	4.3k 1.4×	1.5k 0.8×	2.4k 1.4×	1.9k 1.1×	316	13.9k
Ya‐Chen Tina Shih United States	49	7.4k 2.0×	2.8k 0.9×	840 0.4×	1.8k 1.0×	913 0.5×	303	13.2k
Allison M. Deal United States	53	4.8k 1.3×	2.2k 0.7×	823 0.4×	1.7k 0.9×	1.9k 1.1×	403	10.7k
Kent A. Griffith United States	60	4.3k 1.2×	1.9k 0.6×	986 0.5×	1.6k 0.9×	1.9k 1.1×	277	12.8k

Countries citing papers authored by Michael Brundage

Since Specialization

Citations

This map shows the geographic impact of Michael Brundage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brundage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brundage more than expected).

Fields of papers citing papers by Michael Brundage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Brundage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brundage. The network helps show where Michael Brundage may publish in the future.

Co-authorship network of co-authors of Michael Brundage

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Brundage. A scholar is included among the top collaborators of Michael Brundage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Brundage. Michael Brundage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai‐Kwon, Julia, Elissa Thorner, Claudia Rutherford, Norah L. Crossnohere, & Michael Brundage. (2024). Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide. American Society of Clinical Oncology Educational Book. 44(3). e438512–e438512. 5 indexed citations

Mercieca‐Bebber, Rebecca, Olalekan Lee Aiyegbusi, Madeleine King, et al.. (2022). Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews. Quality of Life Research. 31(10). 2939–2957. 13 indexed citations

Snyder, Claire, Norah L. Crossnohere, Madeleine King, et al.. (2022). The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials. Clinical Trials. 19(3). 277–284. 14 indexed citations

Brown, Erika, Ross Halperin, Michael Brundage, et al.. (2021). Patient Engagement: an Assessment of Canadian Radiotherapy Programs’ Current Practices, Perceived Barriers, and Facilitators. Journal of Cancer Education. 37(6). 1834–1841. 2 indexed citations

G, Li, Meredith Giuliani, Michael Brundage, et al.. (2020). Mapping the Current State of Canadian Medical School Oncology Interest Groups. Journal of Cancer Education. 37(1). 203–209. 4 indexed citations

Glicksman, Rachel, et al.. (2019). The Capital Investment Strategy for Radiation therapy in Ontario: A Framework to Ensure Access to Radiation Therapy. Advances in Radiation Oncology. 5(3). 318–324. 4 indexed citations

Bender, Jacqueline L., Deb Feldman‐Stewart, Christine Tong, et al.. (2019). Health-Related Internet Use Among Men With Prostate Cancer in Canada: Cancer Registry Survey Study. Journal of Medical Internet Research. 21(11). e14241–e14241. 23 indexed citations

Retzer, Ameeta, Thomas Keeley, Khaled Ahmed, et al.. (2018). Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol. BMJ Open. 8(2). e017282–e017282. 7 indexed citations

Hanna, Timothy P., et al.. (2017). Variation in Radiotherapy Referral and Treatment for High-risk Pathological Features after Radical Prostatectomy: Results from a Population-based Study. Clinical Oncology. 30(1). 47–56. 4 indexed citations

10.

Raman, Srinivas, Keyue Ding, Edward Chow, et al.. (2016). A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy. Radiotherapy and Oncology. 119(2). 208–212. 15 indexed citations

11.

Ahmed, Khaled, Derek Kyte, Thomas Keeley, et al.. (2016). Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol. BMJ Open. 6(9). e012863–e012863. 16 indexed citations

12.

Mercieca‐Bebber, Rebecca, Michael Palmer, Michael Brundage, et al.. (2016). Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review. BMJ Open. 6(6). e010938–e010938. 85 indexed citations

13.

Croke, Jennifer, Anthony Fyles, Lisa Barbera, et al.. (2016). Radiation therapy quality-of-care indicators for locally advanced cervical cancer: A consensus guideline. Practical Radiation Oncology. 6(5). 315–323. 13 indexed citations

14.

Pereira, José, Martin Chasen, Sean Molloy, et al.. (2015). Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada. Journal of Pain and Symptom Management. 51(4). 662–672.e8. 53 indexed citations

15.

Calvert, Melanie, Michael Brundage, Paul B. Jacobsen, Holger J. Schünemann, & Fabio Efficace. (2013). The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice. Health and Quality of Life Outcomes. 11(1). 184–184. 90 indexed citations

16.

Brundage, Michael, M. Gropp, F. Mefti, et al.. (2012). Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial. Annals of Oncology. 23(8). 2020–2027. 30 indexed citations

17.

Wilkinson, Anna N., et al.. (2008). Managing skeletal related events resulting from bone metastases. BMJ. 337(nov03 1). a2041–a2041. 25 indexed citations

18.

Osoba, David, Andrea Bezjak, Michael Brundage, & Joseph L. Pater. (2007). Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience. Value in Health. 10. S138–S145. 25 indexed citations

19.

Feldman‐Stewart, Deb, et al.. (2000). Practical issues in assisting shared decision‐making. Health Expectations. 3(1). 46–54. 39 indexed citations

20.

Mackillop, William J., Henry L. Fu, Carol F. Quirt, et al.. (1995). Re: Dr. Gerner's response to “waiting for radiotherapy in Ontario”. International Journal of Radiation Oncology*Biology*Physics. 32(3). 895–896. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact